Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160563
Status:
TERMINATED
Last Update Posted:
2015-03-03
First Post:
2005-09-08
Brief Title:
Prevention of Asthma With Levocetirizine 36 Month Treatment in Young Children Suffering From Eczema Atopic Dermatitis and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial NCT00152464
Sponsor:
Organization:
UCB Pharma
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
207
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: